June 19, 2020
Announcing Patient Drop Shipping
In an effort to support the changes that COVID-19 has brought about, we are pleased to announce that we have enhanced patient drop-ship capabilities for online supply orders through our Provider Gateway. With the growing number of telemedicine appointments, this feature offers the convenience of direct shipping to a patient's home while reducing office inventory for you.
The cost of drop shipping will vary by state. SpectraCell will continue to pay for the return postage back to the lab for processing.* We hope this enhanced feature will streamline the process of drop shipping test kit supplies to your patients, allowing you to focus on growing your telemedicine practice! As a reminder, we stress that you always provide your patient with a completed requisition form to return with the sample.
If you wish to order supplies for your office, we also encourage you to do this online through the Provider Gateway. We do not charge a fee for supplies sent to your account address or an alternative address for you (the provider).
* Return postage is only covered for the United States (including Puerto Rico) and Canada.
Please Note: We cannot ship to P.O. Box locations.
March 26, 2020
Getting Started with Telehealth
Telehealth has become increasingly important in ensuring the safety of patients and physicians worldwide while maintaining access to healthcare under challenging circumstances where in-patient visits may be limited. If you’re considering adopting telehealth into your practice, we’re here to help!
SpectraCell cares about our customers and their ability to continue serving the needs of their patients and communities, so we’ve put together a quick guide to help you get started offering the same level of care – virtually.
COVID-19 UPDATE – OUR COMMITMENT TO SAFETY
Friday, March 13, 2020
To Our Customers,
Like you, we have been actively monitoring the latest news about the 2019 Novel Coronavirus (2019- nCoV) and remain committed to being transparent in our communication and keeping you updated on recent developments as the situation unfolds.
We recognize the importance of our commitment to proactive and preventative action so we can continue to offer specialty laboratory diagnostics. Our foremost priority is the health and safety of our employees and have enacted an ongoing task force to guide our organization’s swift actions.
As we prepare to navigate these challenging circumstances together, we wanted to reach out to you personally and share how we’re responding to the situation and the measures and resources that are in place, defined principally by the expert guidance provided by the Centers for Disease Control and Prevention (CDC) and local public health authorities.
HOW WE’RE STAYING SAFE, PREPARED, AND OPEN FOR BUSINESS
Enhanced Safety Measures:
- Normal production and testing continue to be performed in our laboratory facility. Additionally, orders will continue to be accepted and processed Tuesday through Saturday for all incoming specimens.
- Effective Monday, March 16th, essential personnel will remain working on site at the corporate office and lab in Houston. All non-essential staff will be working remotely from home.
- Enhanced cleaning and disinfecting protocols have been implemented across all touchpoints throughout our facility, using CDC-recommended and EPA-approved cleaning agents. Additionally, laboratory personnel have been briefed and trained on new measures to ensure specimen integrity.
- Hand sanitizer stations are available and refilled on an ongoing basis.
- Employees who are feeling ill are being told to stay home and seek medical attention.
- In response to new preparedness protocols and staffing modifications, it’s possible customers may experience some service interruptions. Phone calls will be monitored throughout business hours; however, we do anticipate extended wait times. For immediate assistance, we highly encourage you to visit our Contact page on our website and email your requests. Support personnel has been increased to monitor and triage incoming emails, enabling a faster response time via this method.
- Report access will continue to default to electronic delivery via portal. For your safety and ours, we will temporarily discontinue printing and mailing reports for the few clients who remain enrolled to receive hard copy results. This special circumstance option will revert to faxed reports, using the fax number on file. If your account falls into this limited category, please email your current fax # to your representative or firstname.lastname@example.org.
- At present, our reporting schedule remains unchanged. If we encounter circumstances that affect our ability to follow the reporting schedule we announced yesterday, we will keep you informed.
Best Practices for Sample Submission
The CDC has published criteria to assess a patient for consistent symptoms and stated risk factors (see link below). If a patient is suspected of having 2019-nCoV, contact your state public health laboratory for further instructions.
- SpectraCell does not collect or process specimens from patients confirmed to have or suspected of having 2019-nCoV.
- SpectraCell does not test specimens to rule out 2019-nCoV.
- Do not submit specimens to SpectraCell for any patients suspected of having 2019-nCoV until laboratory testing is completed by the CDC and 2019-nCoV has been ruled out.
Our executive team is closely monitoring guidance from the WHO, CDC, and OSHA to ensure that our policies and practices continue to promote the health and safety of our team members. We will continue to take proactive steps in mitigating the spread of this novel virus while maintaining our ability to serve you.
On behalf of everyone at SpectraCell, thank you for your support and continued business.
For 2019-nCoV criteria, visit the CDC website at: https://www.cdc.gov/coronavirus/2019-nCoV/clinical-criteria.html